Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: BJU Int. 2023 Aug 2;133(1):63–70. doi: 10.1111/bju.16127

Table 1.

Patients’ demographics and tumor characteristics of NMIBC patients who underwent adequate BCG, stratified by age group.

Overall Population (N=632) Age≤70 (N=355) Age>70 (N=277)
Characteristic N % N % N % p-value
Gender 0.3
 Male 505 79.9 278 78.3 227 82.0
Smoker 0.7
 Never 203 32.2 116 32.8 87 31.4
 Current/Past 428 67.8 238 67.2 190 68.6
Grade 0.13
 High 574 90.8 317 89.3 257 92.8
Stage of entry TURBT 0.6
 Ta 306 48.4 168 47.3 138 49.8
 Tis 48 7.6 25 7.0 23 8.3
 T1 278 44.0 162 45.6 116 41.9
Tumor 0.11
 Recurrent 209 33.1 108 30.4 101 36.5
Variant Histology 0.6
 Yes 27 4.3 14 4.0 13 4.7
Tumor Size>3 cm 0.7
 Yes 312 52.7 179 53.3 133 52.0
LVI 0.7
 Yes 7 1.1 3 0.9 4 1.5
Concomitant CIS 0.07
 Yes 202 32.0 103 29.0 99 35.7
Focality 0.052
 Multiple 312 49.6 163 46.2 149 54.0
Prior BCG 0.4
 Yes 51 8.1 26 7.3 25 9.0
Peri-operative Intravesical Chemotherapy 0.5
 Yes 79 12.8 47 13.5 32 11.9
Restaging TUR 0.013
 Yes 391 62.0 235 66.2 156 56.5

TURBT: Transurethral resection of bladder; LVI: Lymphovascular invasion, CIS: carcinoma in situ. BCG: Bacillus Calmette-Guerin